Reference
NCCN guidelines by tumor type
50 entries.
Entries
50
Breast Cancer
Genetic testing (BRCA), HER2/ER/PR receptor status, lymph node assessment
Colon Cancer
Stage (TNM), MSI/dMMR, KRAS/NRAS/BRAF, HER2, RAS, MSI
Rectal Cancer
Stage, MSI/dMMR, MRI for local staging, KRAS/NRAS/BRAF
Pancreatic Cancer
Performance status, resectability, BRCA, MSI, NTRK
Gastric Cancer
Stage, HER2, PD-L1, MSI, EBV
Hepatobiliary Cancers
Liver function (Child-Pugh), HCC vs ICC, FGFR2/IDH1 for ICC
Esophageal & Esophagogastric Junction Cancers
Histology (adeno vs squamous), HER2, PD-L1, MSI
Anal Carcinoma
HPV status, stage, HIV status
Non-Small Cell Lung Cancer (NSCLC)
Stage, PD-L1, EGFR, ALK, ROS1, BRAF, MET, RET, NTRK, KRAS G12C
Small Cell Lung Cancer (SCLC)
Stage (limited vs extensive)
Malignant Pleural Mesothelioma
Stage, histology
Kidney Cancer (RCC)
Histology (clear cell vs non-clear cell), stage, IMDC risk
Bladder Cancer
Stage (NMIBC vs MIBC), FGFR3/HER2
Prostate Cancer
PSA, Gleason, stage, BRCA/MSI for advanced
Testicular Cancer
Stage, histology (seminoma vs non-seminoma), tumor markers
Ovarian Cancer
Stage, histology, BRCA, HRD, MSI
Cervical Cancer
Stage, histology, HPV, PD-L1
Uterine Neoplasms (Endometrial)
Histology, stage, MSI, POLE, PD-L1, HER2
Vulvar Cancer
Stage, histology, HPV
Cutaneous Melanoma
Stage, BRAF, NRAS, KIT, PD-L1
Merkel Cell Carcinoma
MCV+, stage
Basal & Squamous Cell Skin Cancer
Stage, histology
Head and Neck Cancers
HPV status, stage, PD-L1
Thyroid Carcinoma
Histology, stage, BRAF, RET, TERT
Central Nervous System Cancers
Histology (glioma WHO grade, IDH, MGMT, 1p19q), stage
Soft Tissue Sarcoma
Histology, stage, grade
Bone Cancer
Histology, stage
Acute Myeloid Leukemia (AML)
Cytogenetics, FLT3, IDH1/2, NPM1, CEBPA, TP53, MRD
Acute Lymphoblastic Leukemia (ALL)
Cytogenetics, Ph+, MRD, age
Chronic Myeloid Leukemia (CML)
BCR-ABL transcript level, mutation status
Chronic Lymphocytic Leukemia (CLL)
IGHV, TP53/del17p, MRD
Multiple Myeloma
Stage, cytogenetics, MRD
Waldenström Macroglobulinemia
MYD88 mutation, CXCR4
Diffuse Large B-Cell Lymphoma (DLBCL)
Stage, IPI, MYC/BCL2/BCL6, cell of origin
Follicular Lymphoma
Grade, FLIPI
Hodgkin Lymphoma
Stage, IPS, bulk
Myelodysplastic Syndromes
Risk score (IPSS-M), cytogenetics, mutations
Myeloproliferative Neoplasms
JAK2/CALR/MPL, MIPSS
Neuroendocrine and Adrenal Tumors
Grade (Ki-67), site, somatostatin receptor status
Gastrointestinal Stromal Tumor (GIST)
KIT, PDGFRA mutation
Occult Primary (Cancer of Unknown Primary)
Histology, IHC, molecular profiling
Ampullary Adenocarcinoma
Histology, stage
Anal SCC
Stage, HPV
Antiemesis
Emetogenicity of regimen
Adult Cancer Pain
Pain etiology + intensity
Palliative Care
Goals of care, prognosis
Survivorship
Treatment summary
Prevention and Treatment of Cancer-Related Infections
Neutropenia risk, prior infections
Venous Thromboembolic Disease (Cancer)
Khorana score, bleeding risk
Distress Management
Distress thermometer, comorbidities
Contact: hello@approvalhelp.com